Aprogen Biologics Inc. (KRX:003060)
South Korea · Delayed Price · Currency is KRW
363.00
+4.00 (1.11%)
Last updated: Feb 26, 2026, 11:28 AM KST
Revenue by Segment
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|
| Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 | Dec '15 Dec 31, 2015 |
|---|
| 358.95M | 812.16M | - | - | - | | | | | |
| -55.80% | - | - | - | - | | | | | |
Pharmaceutical Business Division | 57.57B | 62.95B | 64.74B | 55.74B | 50.80B | | | | | |
Pharmaceutical Business Division Growth | -8.55% | -2.76% | 16.14% | 9.74% | 2.20% | | | | | |
| 9.45B | 16.87B | 274.43M | - | - | | | | | |
Bio Business Division Growth | -44.00% | 6047.42% | - | - | - | | | | | |
| - | 357.66M | 173.22M | 738.18M | 2.52B | | | | | |
Game Business Division Growth | - | 106.48% | -76.53% | -70.76% | 110.23% | | | | | |
Insulation Business Division | - | 6.37B | - | - | - | | | | | |
| 67.38B | 87.36B | 65.19B | 56.48B | 53.32B | | | | | |
| -22.88% | 34.01% | 15.42% | 5.93% | 4.75% | | | | | |
Source: S&P Global Market Intelligence.